Alercell Appoints Dr. Paul A. Dreschnack to Advisory Board
Alercell has appointed Dr. Paul A. Dreschnack, a Harvard surgeon and four-time Nobel Peace Prize nominee, to its advisory board. Dr. Dreschnack will assist in the clinical translation of Alercell’s LENA Platform, which focuses on pre-symptomatic detection of blood cancers.
Microsurgeon and stemcell therapeutics pioneer joins Alercell to inform clinical translation of the LENA Platform for pre-symptomatic detection of blood cancers
BOZEMAN, MT, UNITED STATES, June 2, 2026 /EINPresswire.com/ — Alercell, Inc., a Montana- …
